↓ Skip to main content

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients.

Overview of attention for article published in Current Pharmaceutical Design, January 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
1 patent
guideline
1 clinical guideline source

Readers on

mendeley
29 Mendeley